Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

about

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.Role and therapeutic value of dendritic cells in central nervous system autoimmunity.Control of immune-mediated pathology via the aryl hydrocarbon receptor.

P2860

Q34286754-6D466CC0-4F9D-4EBA-81D0-FF1B9FE2E865 Q34924088-1EEBC7B8-183C-41C2-9B2E-284FA5D95C3F Q39374093-0AE51952-18F1-4EB4-A849-4AE12743D022

P2860

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

Item

http://www.wikidata.org/entity/Q48846829

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@en

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@nl

type

Item

label

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@en

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@nl

prefLabel

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@en

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@nl

P1476

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

@en

P2093

Timothy Vollmer

http://www.w3.org/2001/XMLSchema#string

Wolfgang Brück

http://www.w3.org/2001/XMLSchema#string

P2860

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.

Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.

Pathology and disease mechanisms in different stages of multiple sclerosis.

Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.

P2888

nrneurol.2013.234

P304

664-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2013.234

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24275930

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

about

P2860

P2860

Multiple sclerosis: Oral laquinimod for MS--bringing the brain into focus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921